Factors controlling immunoglobulin production and B cell proliferation.

Abstract:

:The proliferation and the differentiation of B lymphocytes is under the control of T cell and macrophage produced cytokines which drive resting B cells to the state of antibody-producing plasma cells. Antibodies exert a feedback control of their own production via their interaction with Fc receptor (FcR) bearing cells and the production of Immunoglobulin-Binding Factors (IBF). The fact that some malignant B cells are sensitive to the same factors as normal B lymphocytes opens the possibility to use cytokines as prognostic or therapeutic tools.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Fridman WH

subject

Has Abstract

pub_date

1991-01-01 00:00:00

pages

195-201

issue

2

eissn

0007-4551

issn

1769-6917

journal_volume

78

pub_type

杂志文章,评审
  • [Small cell carcinoma. Incidence, histopathology and anatomical features. Analysis of 465 autopsied bronchopulmonary carcinomas (author's transl)].

    abstract::465 patients with broncho-pulmonary malignant tumors have been autopsied. Small cell carcinoma was diagnosed in 22.5 per cent of these patients. The histo-cytological variants of these tumors (lymphocytoid, polygonal, fusiform and polymorphic) had the same general characteristics (age, sex, survival) and a similar cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chomette G,Auriol M,Tranbaloc P,Esperandieu O,Guettier C

    更新日期:1982-01-01 00:00:00

  • [Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French].

    abstract:BACKGROUND:Depression is an important symptom for many palliative care patients but is rarely identified. It's known to reduce quality of life and impact on palliation of physical symptom. These physical symptoms can be improved by an adequate treatment of depression. Many depressed cancer patients are not treated due ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1310

    authors: Rhondali W,Perceau E,Saltel P,Girard R,Filbet M

    更新日期:2011-02-01 00:00:00

  • [Blood amylase: a biological marker in irradiation accidents? Preliminary results obtained at the Gustave-Roussy Institut (GRI) and a literature review].

    abstract::The retrospective evaluation of the dose after an irradiation accident is of paramount importance; it allows an adequate selection of patients and the most appropriate treatment can then be proposed. Classical physical dosimetry often lacks precision for dose assessment in such accidents. Cytogenetics, usually more re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hennequin C,Cosset JM,Cailleux PE,Girinsky T,Ganem G,Hubert D,Comoy E,Dutreix J

    更新日期:1989-01-01 00:00:00

  • [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].

    abstract::Despite surgery, post-operative irradiation and adjuvant conventional chemotherapy, prognosis of high-grade gliomas remains poor. Carmustine (BCNU) has been shown to have limited activity at conventional dosage but is still the standard chemotherapy. Activity of chemotherapy is limited by the blood-brain barrier imper...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Linassier C,Destrieux C,Benboubker L,Alcaraz L,Bergemer-Fouquet AM,Jan M,Calais G,Colombat P

    更新日期:2001-09-01 00:00:00

  • [Nab-paclitaxel].

    abstract::Paclitaxel is conventionally used in a wide range of oncology indications. Nab-paclitaxel is synthesized by a process of high pressure homogenization of paclitaxel in the presence of human albumin and it was originally developed to reduce the toxicity usually associated with cremophor in soluble paclitaxel and to incr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.020

    authors: Lopez-Trabada Ataz D,Dumont S,André T

    更新日期:2015-06-01 00:00:00

  • Genetics of rectal cancer.

    abstract::Two operational subdivisions of hereditary colorectal cancer susceptibility are those with and those without premalignant adenomatous colonic polyp expression. In both of these subdivisions, reliable biomarkers of gene carriage would be of value in patient management as we have previously emphasized. Consideration mus...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lynch HT,Schuelke GS,Lynch JF

    更新日期:1984-01-01 00:00:00

  • [Infiltrating carcinoma of the uterine cervix: epidemiology, prognostic factors, therapeutic strategies].

    abstract::In industrialized countries cervical cancer has decreased over the past decades. This, thanks to wide spread screening campaigns of precancerous lesions and microinvasive diseases through regular pap smears starting from the beginning of sexual activity. The diagnostic is realized earlier, thus increasing the rate of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pereira R,Renard A,Boulbair F,Touboul E,Lefranc JP

    更新日期:1998-11-01 00:00:00

  • [Acute lymphoblastic leukemia and pregnancy. Apropos of a case].

    abstract::The authors report on a case of a woman with acute lymphoblastic leukemia treated with cortisone therapy during pregnancy. No problems were encountered during the gestational period or at parturition; and no maternal or neonatal complications were observed. ...

    journal_title:Bulletin du cancer

    pub_type: 信件

    doi:

    authors: Hamdoun L,Zeineb NB,Ferchiou M,Zhioua F,Meriah S

    更新日期:1992-01-01 00:00:00

  • [Gastrointestinal stromal tumours in pediatrics: a summary of the literature on this orphan disease].

    abstract::Recommendations for the management of gastrointestinal stromal tumours (GIST) in children and adolescents do presently not exist. Thus, a summary of the current literature was conducted serving as a basis for the development of optimal management strategies for childhood GIST. Pediatric cases of GIST may occur sporadi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1296

    authors: Verschuur A,André N,Blay JY

    更新日期:2011-01-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [Medicinal plants in cancer patients: current practices and evaluation data].

    abstract::Many complementary and alternatives medicines are offered to patients with cancer. Among them, herbal medicines have a substantial place. These plants are mainly used to reduce adverse effects of anticancer treatments and for specific anticancer properties. Our review shows that only few clinical data support medicina...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1741

    authors: Huet M

    更新日期:2013-05-01 00:00:00

  • [Gene therapy of primary cancers of the liver: hopes and realities].

    abstract::Many efforts have been devoted to the development of gene therapy for primary liver tumors. This has been hampered by the absence of efficient gene transfer vectors for delivering genes into hepatoma cells in vivo. Also it remains to determine which type of gene has to be used to achieve complete tumor regression. Rec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ferry N

    更新日期:1997-04-01 00:00:00

  • [Study of mdm2 gene amplification in primary breast tumors].

    abstract::mdm2 (mouse double minute) protein seems lead to p53 inactivation and therefore might potentially play a role in carcinogenesis. We have studied mdm2 gene amplification from 239 primary breast cancer tissues. mdm2 gene was amplified in 10% of cases (25/239). mdm2 amplification was associated with c-erbB2 amplification...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fontana X,Ferrari P,Abbes M,Monticelli J,Namer M,Bussière F

    更新日期:1994-07-01 00:00:00

  • [Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

    abstract::Treatment of patients with small-cell lung cancer (SCLC) remains disappointing despite high initial complete response rates. The dramatic initial chemosensitivity of tumor cells is frustrated by the early emergence of chemoresistant clonogenic cells, regardless of front line treatments. Although the dose relationship ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,meta分析,随机对照试验

    doi:

    authors: Le Chevalier T,Le Cesne A,Arriagada R

    更新日期:1995-01-01 00:00:00

  • [Pulmonary sarcomatoid carcinoma].

    abstract::Pulmonary sarcomatoid carcinomas are a rare group of tumors accounting for about 1 % of non-small cell lung carcinoma (NSCLC). In 2004, World Health Organization classification united under this name all the carcinomas with sarcomatous or sarcomatous-like component with spindle cell or giant cell appearance. There are...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1619

    authors: Vieira T,Duruisseaux M,Ruppert AM,Cadranel J,Antoine M,Wislez M

    更新日期:2012-10-01 00:00:00

  • [Major therapeutic advances in the treatment of metastatic melanoma].

    abstract::The treatment of metastatic melanoma is presently in complete revolution. Two molecules have recently been authorized for this indication. These treatments have a very different mechanism of action compared to previous chemotherapies. Vemurafenib is a targeted therapy, which blocks BRAF selectively. This molecule indu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1594

    authors: Mateus C,Robert C

    更新日期:2012-06-01 00:00:00

  • [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].

    abstract::From a series of 89 clinically inflammatory breast cancers, the authors settle a subgroup of tumors, the infiltrative ductal carcinomas with a pleomorphic structure. They have better histological and hormonal prognostic criteria than the other carcinomas, especially the infiltrative ductal carcinomas with an atypical ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Wafflart J,Trojani M,Durand M

    更新日期:1983-01-01 00:00:00

  • [Role of psychological factors in cancerogenesis and the development of cancerous disease].

    abstract::Psychoanalysts working in cancerology have to face three main difficulties concerning their methodology: the selection of representative populations, the identification of prospective factors and the choice and definition of the data they need to collect. Four examples are given hereafter: a prospective study on the p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Raimbault E

    更新日期:1986-01-01 00:00:00

  • [Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic hematopoietic cell transplantation is a potentially curative option, this is true particularly in the case of after autologous stem cell transplantatio...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.10.018

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [Percutaneous ablation of metastases: where are we and new techniques].

    abstract::When a metastatic disease is localized and slowly evolving either spontaneously or after a general treatment, a local treatment may be proposed. For about 15 years, image-guided percutaneous ablation has been developed which allows to treat tumors with temperature modifications. These mini-invasive techniques may be r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1728

    authors: Palussière J,Buy X,Fonck M

    更新日期:2013-04-01 00:00:00

  • [Gemcitabine and pemetrexed in genito-urinary tumors treatment].

    abstract::Among genito-urinary tumors, gemcitabine is indicated only for the treatment of locally advanced and metastatic urothelial cancer. The combination of gemcitabine and cisplatin is a new standard in this disease. Gemcitabine shows activity in refractory germ cell tumors. In salvage treatment its role is ongoing evaluati...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fléchon A

    更新日期:2007-01-01 00:00:00

  • [Hypoxia and angiogenesis].

    abstract::The presence of hypoxic regions within solid tumours is associated with a more malignant tumour phenotype and worse prognosis. To obtain a blood supply and protect against cellular damage and death, oxygen-deprived cells in tumours alter gene expression, resulting in resistance to therapy. Hypoxia is sensed at the cel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Simon JM

    更新日期:2007-07-01 00:00:00

  • A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

    abstract::Twenty-eight patients with poor prognosis, advanced metastatic non seminomatous germ cell tumors (NSGCT) were treated with early high dose chemotherapy and autologous bone marrow transplantation (ABMT) rescue. The primary tumor was testicular in 19 patients and extragonadal in nine patients. For 19 patients with a tes...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Droz JP,Pico JL,Ghosn M,Kramar A,Rey A,Ostronoff M,Baume D

    更新日期:1992-01-01 00:00:00

  • [First line chemotherapy of advanced epithelial ovarian cancer].

    abstract::The treatment of the advanced ovarian adenocarcinoma, most frequently stage at diagnostic, relies on association of surgery and chemotherapy. The current standard is the association carboplatine-paclitaxel. In spite of this treatment, relapses are frequent, and the prognosis thus remains very reserved. Presently the c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0987

    authors: Lhommé C,Even C,Morice P,Balleyguier C,Petrella M,Gouy S,Uzan C,Duvillard P,Pautier P

    更新日期:2009-12-01 00:00:00

  • [Association of radiotherapy and hormonotherapy in locally advanced prostate cancer].

    abstract::Combination of radiotherapy and androgen deprivation is now considered as the standard of care for patients with a localized prostate cancer but poor prognostic factors. Two groups of randomized trials have led to this recommendation. Some have compared radiotherapy alone versus hormonal treatment and radiotherapy: th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1567

    authors: Quero L,Wong-Hee-Kam S,Rivera S,Hennequin C

    更新日期:2012-07-01 00:00:00

  • [Ovarian cancer in France. Epidemiological, clinical and histological status].

    abstract::With 2 436 deaths in 1979, ovarian cancer is relatively infrequent in France comprising but 5 per cent of female mortality from malignant disease. However, the rate of increase in mortality is considerable, 70 per cent between 1955 and 1979 or 2,9 per cent per year, greater than that for female bladder and breast canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Berlie J,Tournade MF,Chauvergne J,Bastien H

    更新日期:1983-01-01 00:00:00

  • [Cancer of the prostate: the markers other than prostatic acid phosphatase].

    abstract::The biological diagnosis of prostatic carcinoma in relation with benign prostatic hypertrophy is essentially realized by the evaluation of plasma PAP or medullar PAP, the increase of which rises to 70% of the cases. This evaluation contains also other biochemical markers such as CK-BB, glucose-6-phosphate dehydrogenas...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Soula G

    更新日期:1985-01-01 00:00:00

  • [Pulmonary malt lymphoma].

    abstract::This review will describe the current knowledge in the pathophysiology, diagnosis, prognosis and treatment of pulmonary MALT (Mucosa Associated Lymphoid Tissue) lymphoma. Pulmonary MALT lymphomas are low-grade B cell lymphoma and are the most frequent lymphomas arising from the lung. Tumour cells arise from mucosa ass...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1885

    authors: Borie R,Antoine M,Cadranel J,Wislez M

    更新日期:2014-02-01 00:00:00

  • [Preclinical evaluation of anticancer drugs: a model remaining a model!].

    abstract::Two criteria are firstly used in the selection of new anticancer agents:--originality of the mechanism of action and significant experimental antitumor activity in an in vivo animal model. Murine tumors grafted in syngenic mice and human tumor xenografts implanted in nude mice are old models which continue to be widel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lavelle F

    更新日期:1998-10-01 00:00:00

  • [Place of neoadjuvant treatments in oesophageal cancers care].

    abstract::Esophageal cancer has a poor prognosis. Recent epidemiological data has shown a modification of histologic types, as adenocarcinoma represents more than 50% of all patients newly diagnosed. Despite progress of surgery, overall survival at 5 years is still about 20% for resectable tumors, supporting the need for additi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Créhange G,Lorchel F,Bosset JF

    更新日期:2006-11-01 00:00:00